Other Species / Isoforms
  AP-4 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y3-p
_____MEyFMVPTQk
0 1
AP-4 (human) _____MEyFMVPTQk Y3-p
AP-4 (mouse) _____MEYFMVPTQK Y3
AP-4 (rat) _____MEYFMVPTQK Y3
K10-ub
yFMVPTQkVPsLQHF
0 2
AP-4 (human) yFMVPTQkVPsLQHF K10-ub
AP-4 (mouse) YFMVPTQKVPSLQHF K10
AP-4 (rat) YFMVPTQKVPSLQHF K10
S13-p
VPTQkVPsLQHFRKT
0 1
AP-4 (human) VPTQkVPsLQHFRKT S13-p
AP-4 (mouse) VPTQKVPSLQHFRKT S13
AP-4 (rat) VPTQKVPSLQHFRKT S13
S30-p
EVIGGLCsLANIPLt
0 1
AP-4 (human) EVIGGLCsLANIPLt S30-p
AP-4 (mouse) EVIGGLCSLANIPLT S30
AP-4 (rat) EVIGGLCSLANIPLT S30
T37-p
sLANIPLtPETQRDQ
0 28
AP-4 (human) sLANIPLtPETQRDQ T37-p
AP-4 (mouse) SLANIPLTPETQRDQ T37
AP-4 (rat) SLANIPLTPETQRDQ T37
S70
SINAGFQSLKTLIPH
0 1
AP-4 (human) SINAGFQSLKTLIPH S70
AP-4 (mouse) SINAGFQsLKtLIPH S70-p
AP-4 (rat) SINAGFQSLKTLIPH S70
T73
AGFQSLKTLIPHTDG
0 1
AP-4 (human) AGFQSLKTLIPHTDG T73
AP-4 (mouse) AGFQsLKtLIPHTDG T73-p
AP-4 (rat) AGFQSLKTLIPHTDG T73
K103-ub
IFSLEQEkTRLLQQN
0 1
AP-4 (human) IFSLEQEkTRLLQQN K103-ub
AP-4 (mouse) IFSLEQEKTRLLQQN K103
AP-4 (rat) IFSLEQEKTRLLQQN K103
K114-ub
LQQNTQLkRFIQELs
0 6
AP-4 (human) LQQNTQLkRFIQELs K114-ub
AP-4 (mouse) LQQNTQLKRFIQELs K114
AP-4 (rat) LQQNTQLKRFIQELS K114
S121-p
kRFIQELsGssPkRR
0 6
AP-4 (human) kRFIQELsGssPkRR S121-p
AP-4 (mouse) KRFIQELsGssPKRR S121-p
AP-4 (rat) KRFIQELSGSsPKRR S121
S123-p
FIQELsGssPkRRRA
Upstream
0 12
Treatment
  • nocodazole
  • rapamycin
AP-4 (human) FIQELsGssPkRRRA S123-p
AP-4 (mouse) FIQELsGssPKRRRA S123-p
AP-4 (rat) FIQELSGSsPKRRRA S123
S124-p
IQELsGssPkRRRAE
Upstream
0 59
Treatment
  • anti-CD3
  • selumetinib
  • vemurafenib
AP-4 (human) IQELsGssPkRRRAE S124-p
AP-4 (mouse) IQELsGssPKRRRAE S124-p
AP-4 (rat) IQELSGSsPKRRRAE S124-p
K126-ub
ELsGssPkRRRAEDk
0 1
AP-4 (human) ELsGssPkRRRAEDk K126-ub
AP-4 (mouse) ELsGssPKRRRAEDK K126
AP-4 (rat) ELSGSsPKRRRAEDK K126
K133-ub
kRRRAEDkDEGIGsP
0 1
AP-4 (human) kRRRAEDkDEGIGsP K133-ub
AP-4 (mouse) KRRRAEDKDEGIGsP K133
AP-4 (rat) KRRRAEDKDEGIGsP K133
S139-p
DkDEGIGsPDIWEDE
Upstream
Downstream
1 23
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • cell cycle regulation
Treatment
  • BI_4834
AP-4 (human) DkDEGIGsPDIWEDE S139-p
AP-4 (mouse) DKDEGIGsPDIWEDE S139-p
AP-4 (rat) DKDEGIGsPDIWEDE S139-p
K147-ub
PDIWEDEkAEDLRRE
0 1
AP-4 (human) PDIWEDEkAEDLRRE K147-ub
AP-4 (mouse) PDIWEDEKAEDLRRE K147
AP-4 (rat) PDIWEDEKAEDLRRE K147
K187-ub
EAHMYPEkLkVIAQQ
0 1
AP-4 (human) EAHMYPEkLkVIAQQ K187-ub
AP-4 (mouse) EAHMYPEKLKVIAQQ K187
AP-4 (rat) EAHMYPEKLKVIAQQ K187
K189-ub
HMYPEkLkVIAQQVQ
0 4
AP-4 (human) HMYPEkLkVIAQQVQ K189-ub
AP-4 (mouse) HMYPEKLKVIAQQVQ K189
AP-4 (rat) HMYPEKLKVIAQQVQ K189
K211-ub
VRLLHQEkLEREQQQ
0 1
AP-4 (human) VRLLHQEkLEREQQQ K211-ub
AP-4 (mouse) VRLLHQEKLEREQQH K211
AP-4 (rat) VRLLHQEKLEREQQH K211
T282-p
AIQHIEGtQEKQELE
0 2
AP-4 (human) AIQHIEGtQEKQELE T282-p
AP-4 (mouse) AIQHIEGTQDKQELE T282
AP-4 (rat) AIQHIEGTQDRQELE T282
K299-ub
QRRAVIVkPVRSCPE
0 1
AP-4 (human) QRRAVIVkPVRSCPE K299-ub
AP-4 (mouse) QRRAVIVKSVRSCPD K299
AP-4 (rat) QRRAVIVKSVRSCPE K299
S332-p
DQSREEPsGDGELP_
0 1
AP-4 (human) DQSREEPsGDGELP_ S332-p
AP-4 (mouse) DQSREEPLGDGELP_ L332
AP-4 (rat) DQSREEPLGDGELP_ L332